How weight-loss drugs are destroying big snacking, erasing billions in sales
“GLP-1 drugs don’t just change what people eat,” Karthik Srinivasan, communications strategy ...
In
Economy
Analyst explains why Indian stocks may sell off after the budget announcement
Indian stocks, especially the nation’s tech sector, will likely face turbulence in ...
Why analysts are not impressed with Trump’s ‘Great Healthcare Plan’
The Trump administration on Thursday unveiled what it called the “Great Healthcare ...
Why CEOs and CISOs are split on AI-driven cyber risk
Artificial intelligence is reshaping cybersecurity faster than many companies can adjust their ...
Netflix earnings preview: investors watch ads, churn and Warner Bros. deal
Netflix is preparing to report its fourth-quarter fiscal 2025 earnings after the ...
US stocks open in the green: S&P 500 climbs 0.3%, Nasdaq up 0.5%
US stocks rose on Friday as Wall Street attempted to close out ...
Tesla stocks slip in red: why investors are booking profits ahead of Q4 earnings
Tesla stock (NASDAQ: TSLA) has fallen into the red on Friday as ...
Nvidia stock remains stuck: here is why analysts say ‘buy’ anyway
Nvidia stock was modestly higher on Friday, extending gains from the previous ...